Arsenic induces diabetic effects through beta-cell dysfunction and increased gluconeogenesis in mice

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Liu, Su ^a   Guo, Xuechao ^a   Wu, Bing ^a   Yu, Haiyan ^a   Zhang, Xuxiang ^a   Li, Mei ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; WATER POLLUTANT;

ANIMAL; C57BL MOUSE; CALORIC INTAKE; CHEMICALLY INDUCED; DRUG EFFECTS; GLUCONEOGENESIS; GLUCOSE INTOLERANCE; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PANCREAS; PANCREAS ISLET BETA CELL; PATHOLOGY; PHYSIOLOGY; TOXICITY; WATER POLLUTANT;

ANIMALS; ARSENIC; DIABETES MELLITUS, TYPE 2; ENERGY INTAKE; GLUCONEOGENESIS; GLUCOSE INTOLERANCE; INFLAMMATION; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIPID METABOLISM; MALE; MICE, INBRED C57BL; OXIDATIVE STRESS; PANCREAS; WATER POLLUTANTS, CHEMICAL;

EID: 84925318667     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06894     Document Type: Article

References (51)

1. Inceoglu, B. et al. Acute augmentation of epoxygenated fatty acid levels rapidly reduces pain-related behavior in a rat model of type I diabetes. Proc Natl Acad Sci U S A 109, 11390-5 (2012).
2. Zimmet, P., Alberti, K. G. & Shaw, J. Global and societal implications of the diabetes epidemic. Nature 414, 782-7 (2001).
3. Maull, E. A. et al. Evaluation of the association between arsenic and diabetes: A national toxicology program workshop review. Environ Health Perspect 120, 1658-1670 (2012).
4. Hectors, T. L. M. et al. Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function. Diabetologia 54, 1273-1290 (2011).
5. Navas-Acien, A. et al. Arsenic exposure and type 2 diabetes: A systematic review of the experimental and epidemiologic evidence. Environ Health Perspect 114, 641-648 (2006).
6. Islam, M. R. et al. Association between type 2 diabetes and chronic arsenic exposure in drinking water: Across sectional study in Bangladesh. Environ Health 11, 38 (2012).
7. Tseng, C. H. et al. Long-term arsenic exposure and incidence of non-insulindependent diabetes mellitus: A cohort study in arseniasis-hyperendemic villages in Taiwan. Environ Health Perspect 108, 847-851 (2000).
8. Del Razo, L. M. et al. Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a cross-sectional study in the Zimapan and Lagunera regions in Mexico. Environ Health 10, 73 (2011).
9. Meliker, J. R., Wahl, R. L., Cameron, L. L. & Nriagu, J. O. Arsenic in drinkingwater and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis. Environ Health 6, 4 (2007).
10. Huang, C. F. et al. Arsenic and diabetes: current perspectives. Kaohsiung J Med Sci 27, 402-10 (2011).
11. Kahn, S. E., Hull, R. L. & Utzschneider, K. M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840-6 (2006).
12. Mathis, D., Vence, L. & Benoist, C. beta-Cell death during progression to diabetes. Nature 414, 792-8 (2001).
13. Rhodes, C. J. Type 2 diabetes-a matter of beta-cell life and death? Science 307, 380-4 (2005).
14. Lu, T. H. et al. Arsenic induces pancreatic beta-cell apoptosis via the oxidative stress-regulated mitochondria-dependent and endoplasmic reticulum stresstriggered signaling pathways. Toxicol Lett 201, 15-26 (2011).
15. Diaz-Villasenor, A. et al. Arsenic exposure and Calpain-10 polymorphisms impair the function of pancreatic beta-cells in humans: A pilot study of risk factors for T2DM. PLoS One 8, e51642 (2013).
16. Fu, J. Q. et al. Low-level arsenic impairs glucose-stimulated insulin secretion in pancreatic beta cells: Involvement of cellular adaptive response to oxidative stress. Environ Health Perspect 118, 864-870 (2010).
17. Barrett, J. R. A different diabetes arsenic plus high-fat diet yields an unusual diabetes phenotype in mice. Environ Health Perspect 119, A354-A354 (2011).
18. Paul, D. S., Walton, F. S., Saunders, R. J. & Styblo, M. Characterization of the impaired glucose homeostasis produced in C57BL/6 mice by chronic exposure to arsenic and high-fat diet. Environ Health Perspect 119, 1104-1109 (2011).
19. Paul, D. S., Harmon, A. W., Devesa, V., Thomas, D. J. & Styblo, M. Molecular mechanisms of the diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acid. Environ Health Perspect 115, 734-42 (2007).
20. Liu, S. et al. Impact of iron precipitant on toxicity of arsenic in water: A combined in vivo and in vitro study. Environ Sci Technol 47, 3432-3438 (2013).
21. Mazumder, D. N. Effect of chronic intake of arsenic-contaminated water on liver. Toxicol Appl Pharmacol 206, 169-75 (2005).
22. Smith, A. H. & Steinmaus, C. M. Health effects of arsenic and chromium in drinking water: recent human findings. Annu Rev Public Health 30, 107-22 (2009).
23. Carbrey, J. M. et al. Reduced arsenic clearance and increased toxicity in aquaglyceroporin-9-null mice. Proc Natl Acad Sci U S A 106, 15956-60 (2009).
24. Muoio, D. M. & Newgard, C. B. Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 9, 193-205 (2008).
25. Ghatak, S. et al. Oxidative stress and hepatic stellate cell activation are key events in arsenic induced liver fibrosis in mice. Toxicol Appl Pharmacol 251, 59-69 (2011).
26. Kitchin, K. T. & Conolly, R. Arsenic-induced carcinogenesis-oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment. Chem Res Toxicol 23, 327-335 (2010).
27. Smith, B. W. & Adams, L. A. Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nat Rev Endocrinol 7, 456-65 (2011).
28. Dey, A. & Lakshmanan, J. The role of antioxidants and other agents in alleviating hyperglycemia mediated oxidative stress and injury in liver. Food Funct. 4, 1148-84 (2013).
29. Takumi, S. et al. In vivo mutagenicity of arsenite in the livers of gpt delta transgenic mice. Mutat Res 760, 42-7 (2014).
30. De Vizcaya-Ruiz, A., Barbier, O., Ruiz-Ramos, R. & Cebrian, M. E. Biomarkers of oxidative stress and damage in human populations exposed to arsenic. Mutat Res 674, 85-92 (2009).
31. Laplante, M. & Sabatini, D. M. mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis. Proc Natl Acad Sci U S A 107, 3281-3282 (2010).
32. Beale, E. G., Hammer, R. E., Antoine, B. & Forest, C. Disregulated glyceroneogenesis: PCK1 as a candidate diabetes and obesity gene. Trends Endocrinol Metab 15, 129-135 (2004).
33. Boden, G. Effects of free fatty acids on gluconeogenesis and glycogenolysis. Life Sci 72, 977-88 (2003).
34. Staehr, P. et al. Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis. Diabetes 52, 260-7 (2003).
35. Rains, J. L. & Jain, S. K. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 50, 567-575 (2011).
36. Zavodnik, I. B., Dremza, I. K., Lapshina, E. A. & Cheshchevik, V. T. Diabetes mellitus: metabolic effects and oxidative stress. Biol Membr 28, 83-94 (2011).
37. Cho, H. Protein tyrosine phosphatase 1B (PTP1B) and obesity. Vitam Horm 91, 405-24 (2013).
38. Leto, D. & Saltiel, A. R. Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol 13, 383-96 (2012).
39. Guo, S. D. Insulin signaling, resistance, and metabolic syndrome: insights from mouse models into disease mechanisms. J Endocrinol 220, T1-T23 (2014).
40. Diez, J. J. & Iglesias, P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 148, 293-300 (2003).
41. Carbone, C. J. et al. Protein tyrosine phosphatase 1B is a key regulator of IFNAR1 endocytosis and a target for antiviral therapies. Proc Natl Acad Sci U S A 109, 19226-19231 (2012).
42. Zhang, S. et al. Correlative and quantitative 1H NMR-based metabolomics reveals specific metabolic pathway disturbances in diabetic rats. Anal Biochem 383, 76-84 (2008).
43. Tian, N. et al. NMR-based metabonomic study of Chinese medicine Gegen Qinlian Decoction as an effective treatment for type 2 diabetes in rats. Metabolomics 9, 1228-1242 (2013).
44. Friedrich, N. Metabolomics in diabetes research. J Endocrinol 215, 29-42 (2012).
45. Gall, W. E. et al. alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One 5, e10883 (2010).
46. Burgess, S. C. et al. Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver. Cell Metab 5, 313-320 (2007).
47. Champagne, C. D., Houser, D. S., Fowler, M. A., Costa, D. P. & Crocker, D. E. Gluconeogenesis is associated with high rates of tricarboxylic acid and pyruvate cycling in fasting northern elephant seals. Am J Physiol Regul Integr Comp Physiol 303, R340-R352 (2012).
48. Wallage, T. M., Levy, J. C. & Matthews, D. R. Use and Abuse of HOMA Modeling. Diabetes Care 27, 1487-1495 (2004).
49. Zhang, X. et al. Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS One 7, e42529 (2012).
50. Wiele, T. V. d. et al. Arsenic metabolism by human gut microbiota upon in vitro digestion of contaminated soils. Environ Health Perspect 118, 1004-1009 (2010).
51. Xia, J., Mandal, R., Sinelnikov, I. V., Broadhurst, D. & Wishart, D. S. MetaboAnalyst 2.0 - a comprehensive server for metabolomic data analysis. Nucleic Acids Res 40, W127-33 (2012).